ホームポートフォリオウォッチリストコミュニティ発見スクリーナー
NOT FOR DISTRIBUTION

LANXESS Aktiengesellschaft

XTRA:LXS 株式レポート

時価総額:€1.2b

  • 会社概要
    • 評価
    • 将来の成長
    • 過去の実績
    • 財務の健全性
    • 配当金
  • マネジメント
  • 所有権
  • その他の情報
  • 株式コミュニティ

LANXESS 過去の業績

過去 基準チェック /06

LANXESSの収益は年間平均-48%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間3.5% 3.6%割合で 減少しています。

主要情報

-47.99%

収益成長率

-47.99%

EPS成長率

Chemicals 業界の成長12.41%
収益成長率-3.57%
株主資本利益率-19.14%
ネット・マージン-12.06%
次回の業績アップデート05 Nov 2026

最近の業績更新

Recent updates

User avatar
ナラティブ更新 • Jul 17

LXS: Future Rally Looks Vulnerable As Middle East Conflict Risks Deepen

LANXESS sees its analyst derived fair value estimate move from €11.00 to €12.50, as analysts factor in modestly adjusted growth assumptions, sharply lower profit margin expectations, and a much higher future P/E multiple reflected in recent price target changes between €13 and €18. Analyst Commentary Recent commentary on LANXESS has tilted clearly cautious, with several bearish analysts revisiting both ratings and price targets.
分析記事 • Jun 20

LANXESS (XTRA:LXS) Stock Could Be 4.4% Undervalued After Bond Issue And Ownership Shifts

LANXESS (XTRA:LXS) has drawn investor attention after completing a €494.53 million senior unsecured notes offering due 2031, while recent voting rights disclosures from Stowers Institute and JPMorgan highlight shifting institutional ownership. See our latest analysis for LANXESS. At a share price of €17.12, LANXESS has seen a 7.74% 1-day share price return and a 46.95% 90-day share price return, while the 1-year total shareholder return is down 28.67%. This suggests that recent momentum has...
User avatar
ナラティブ更新 • Jun 17

LXS: Mixed Bank Downgrades Will Drive Bullish Repricing On Middle East Risk

The analyst price target for LANXESS has been reduced by €0.61, as analysts factor in recent downgrades and lower price targets related to concerns about pricing, balance sheet strength and demand risks highlighted in recent research. Analyst Commentary Recent research on LANXESS reflects a cautious tone overall, but there are still some constructive elements that matter for how you think about the stock's valuation and execution risk.
User avatar
ナラティブ更新 • Jun 02

LXS: Fair Outlook Flags Limited Upside As Middle East Risk Deepens

LANXESS's fair value estimate is revised from €14.0 to €11.0 as analysts reset price targets following multiple downgrades, citing limited perceived upside after the share price rally, along with fresh concerns around pricing, demand resilience, and the balance sheet linked to the Middle East conflict. Analyst Commentary Recent research updates on LANXESS point to a clear shift toward caution, with several large houses cutting ratings and trimming price targets.
分析記事 • May 09

Here's What Analysts Are Forecasting For LANXESS Aktiengesellschaft (ETR:LXS) After Its First-Quarter Results

LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders are probably feeling a little disappointed, since its shares fell...
User avatar
ナラティブ更新 • May 01

LXS: Mixed Bank Ratings Will Drive Bullish Repricing On Higher Future P/E

Analysts have adjusted the price target on LANXESS from about €28.86 to about €26.29. This reflects updated views on faster revenue growth, much thinner profit margins, and a much higher assumed future P/E multiple after recent mixed rating changes from major banks.
User avatar
ナラティブ更新 • Apr 16

LXS: Future Earnings Multiples Will Balance Mixed Ratings And Margin Execution Risk

LANXESS' updated analyst price target edges up to about €17.91 from roughly €17.81, as analysts factor in slightly higher assumed revenue growth and a marginally richer future P/E, partly offset by a more cautious profit margin view following mixed recent rating changes. Analyst Commentary Recent research views on LANXESS are mixed, with both upgrades and a downgrade pointing to different expectations around execution, earnings power and valuation risk.
User avatar
ナラティブ更新 • Apr 02

LXS: Future Earnings Multiples Will Reflect Mixed Rating Shifts And Execution Risk

Analysts have trimmed the LANXESS price target from about €18.66 to around €17.81, reflecting mixed recent research that balances reduced fair value and profit margin assumptions with updated views on growth and valuation following both target cuts and rating changes across the Street. Analyst Commentary Recent research on LANXESS shows a split tape, with some firms turning more positive on the shares while others are taking a more cautious line on execution and fair value assumptions.
User avatar
ナラティブ更新 • Mar 19

LXS: Fair Outlook Balances Higher Risk Assumptions With Recent Upgrade

Analysts have trimmed their fair value estimate for LANXESS from €17.0 to €14.0, reflecting recent price target cuts such as Deutsche Bank's move to €17 and updated assumptions for growth, margins and risk, even as some research, including a recent Goldman Sachs upgrade, highlights potential longer term upside drivers. Analyst Commentary Recent research shows a split view on LANXESS, with some highlighting possible longer term drivers while others are reining in expectations.
User avatar
ナラティブ更新 • Mar 05

LXS: Upgrade And Reset Expectations Will Drive Bullish Repricing Potential

Analysts have adjusted their price targets on LANXESS, with the latest change lowering one view from €18.50 to €17. This reflects updated assumptions around discount rates, modest revenue growth and expected P/E levels.
User avatar
ナラティブ更新 • Feb 18

LXS: Upgrade And Margin Execution Are Expected To Drive Bullish Repricing

LANXESS's consensus analyst price target has moved modestly lower, with recent cuts to €17 and €15 cited by analysts who point to updated assumptions around discount rates, profit margins, and forward P/E expectations. Analyst Commentary Recent research on LANXESS highlights a mix of caution and optimism, with some bullish analysts focusing on potential upside if the company can execute against current expectations on margins and earnings quality.
User avatar
ナラティブ更新 • Feb 04

LXS: Sector Headwinds And Execution Discipline Will Drive Future Bullish Repricing

Analysts have trimmed their price expectations for LANXESS, reflected in a slightly lower fair value estimate of about €28.87 from €29.24. They cite a series of reduced Street price targets and more cautious sector views, even as underlying model assumptions such as revenue growth, profit margin and future P/E remain broadly consistent.
User avatar
ナラティブ更新 • Jan 21

LXS: Future Earnings Multiples Will Reward Execution Despite Sector Downgrades

Our fair value estimate for LANXESS has been reduced from about €20.30 to roughly €18.66, reflecting a cluster of lower price targets and more cautious views from analysts who now generally expect lower growth and apply a slightly higher required return. Analyst Commentary Recent Street research around LANXESS has tilted more cautious, with several firms trimming price targets and highlighting sector headwinds in European chemicals and ingredients.
User avatar
ナラティブ更新 • Jan 06

LXS: Earnings Resilience And Portfolio Actions Will Drive Bullish Repricing

Narrative Update The updated analyst price target framework for LANXESS points to a fair value adjustment from €31.85 to €29.24. This reflects recent target cuts from €21 to €15 at JPMorgan, a downgrade to Underweight with a €15 target at Barclays, and a reduction from €26 to €23 at Citi that collectively signal increased caution among analysts.
分析記事 • Jan 02

A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)

Key Insights The projected fair value for LANXESS is €14.85 based on 2 Stage Free Cash Flow to Equity LANXESS' €17.62...
User avatar
ナラティブ更新 • Dec 17

LXS: Demand Recovery And Margin Actions Will Drive Bullish Repricing

Analysts have trimmed their price target on LANXESS to EUR 15 from EUR 21, citing weaker expected revenue growth, lower profit margins, a higher discount rate, and a richer future P E multiple. Together, these factors reduce estimated fair value from about EUR 37.49 to EUR 31.85 per share.
分析記事 • Dec 15

Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
User avatar
ナラティブ更新 • Dec 03

LXS: Future Earnings Multiples Will Reward Improving Execution Amid Sector Caution

The analyst fair value estimate for LANXESS has been reduced slightly to EUR 20.30 from EUR 20.92, as analysts factor in lower sector sentiment, a modestly softer revenue growth outlook, and recent cuts to Street price targets across the European chemicals space. Analyst Commentary Street research on LANXESS has turned more cautious, with recent revisions reflecting concerns around sector headwinds, execution risk, and a less supportive valuation backdrop.
User avatar
ナラティブ更新 • Nov 19

LXS: Future Earnings Multiples Will Reflect Sector Caution And Resilient Performance

LANXESS’s analyst price target has been revised downward from €24.55 to €20.92 as analysts cite sector-wide caution and a reassessment of fair value within the European chemicals industry. Analyst Commentary The recent series of updates from street research highlights both supportive and cautious sentiment regarding LANXESS’s outlook, reflecting the evolving landscape in the European chemicals sector.
User avatar
ナラティブ更新 • Nov 05

LXS: Future Resilience Will Support Stability Amid Sector Pressures

Analysts have modestly reduced their price target for LANXESS by approximately EUR 0.30. This adjustment reflects more cautious growth and valuation assumptions in light of recent sector performance and peer comparisons.
User avatar
ナラティブ更新 • Oct 22

Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts

The analyst price target for LANXESS has been reduced by approximately EUR 0.67 to EUR 24.85. This change reflects revised expectations on revenue growth and profitability as analysts adjust their outlook in light of recent performance and updated industry assessments.
User avatar
ナラティブ更新 • Oct 08

Portfolio Optimization And Sustainable Initiatives Will Unlock Market Opportunities

The analyst consensus price target for LANXESS has been reduced from €26.79 to €25.52. Analysts cite increased caution due to reduced expected growth and valuation concerns following the company's recent outperformance among peers.
User avatar
ナラティブ更新 • Aug 29

Accelerated FORWARD! Program Set To Improve Future Performance

Analysts have lowered LANXESS's price target to €26.79, citing ongoing operational headwinds, margin pressure, and delayed recovery in key markets, while acknowledging that cost measures will take time to improve earnings. Analyst Commentary Bearish analysts cite persistent near-term operational headwinds and sluggish demand as reasons for lowering price targets.
分析記事 • Jul 03

Is LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 46% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, LANXESS fair value estimate is €47.92 LANXESS is estimated to...
User avatar
新しいナラティブ • Mar 22

Accelerated FORWARD! Program Set To Improve Future Performance

Successful cost savings and portfolio transformation initiatives are boosting profitability, improving margins, and enhancing future earnings potential through strategic divestitures.
分析記事 • Mar 07

Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) 25% Share Price Surge

LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders have had their patience rewarded with a 25% share price jump in the...
分析記事 • Jan 31

LANXESS (ETR:LXS) Use Of Debt Could Be Considered Risky

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Jan 07

Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price

There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...
分析記事 • Oct 30

Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Sep 07

Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price

There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...
分析記事 • Jul 23

Is LANXESS (ETR:LXS) Using Debt Sensibly?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
分析記事 • May 27

Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?

While LANXESS Aktiengesellschaft ( ETR:LXS ) might not have the largest market cap around , it saw a double-digit share...
分析記事 • May 08

Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S

There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.4x is...
分析記事 • Apr 20

Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?

Key Insights The projected fair value for LANXESS is €44.32 based on 2 Stage Free Cash Flow to Equity LANXESS is...
分析記事 • Mar 22

Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Jan 27

What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S

There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...
分析記事 • Dec 05

Is LANXESS (ETR:LXS) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

収支内訳

LANXESS の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

XTRA:LXS 収益、費用、利益 ( )EUR Millions
日付収益収益G+A経費研究開発費
30 Jun 265,545-6691,06093
31 Mar 265,450-6611,06593
31 Dec 255,673-5771,09196
30 Sep 255,888-2431,11897
30 Jun 256,148-1651,164102
31 Mar 256,360-1361,176105
31 Dec 246,366-1771,177104
30 Sep 246,319-6901,167105
30 Jun 246,322-8221,164102
31 Mar 246,422-9511,182100
31 Dec 236,714-8431,23899
30 Sep 237,251-2801,350102
30 Jun 237,835-651,438104
31 Mar 238,0561281,439105
31 Dec 228,0881841,398102
30 Sep 227,7941911,330100
30 Jun 227,1901471,22999
31 Mar 226,6601461,17196
31 Dec 216,1011161,10795
30 Sep 215,9251191,05099
30 Jun 215,8051051,018100
31 Mar 215,7728631,022105
31 Dec 206,1048921,056108
30 Sep 206,2378831,088110
30 Jun 206,4809381,110113
31 Mar 206,7682311,127113
31 Dec 196,8022551,115114
30 Sep 196,5592661,055105
30 Jun 196,6412431,066106
31 Mar 196,7462121,072106
31 Dec 186,8241901,084109
30 Sep 187,0661441,166110
30 Jun 186,9901381,167109
31 Mar 186,873631,165110
31 Dec 176,530231,111103
30 Sep 176,810731,103116
30 Jun 177,021831,087121
31 Mar 177,2521661,072124
31 Dec 167,6991921,116131
30 Sep 167,5902051,092128
30 Jun 167,6221841,093126
31 Mar 167,7841961,097128
31 Dec 157,9021651,078130
30 Sep 158,000821,060134

質の高い収益: LXSは現在利益が出ていません。

利益率の向上: LXSは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: LXSは利益が出ておらず、過去 5 年間で損失は年間48%の割合で増加しています。

成長の加速: LXSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: LXSは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -13.3% ) と比較することは困難です。


株主資本利益率

高いROE: LXSは現在利益が出ていないため、自己資本利益率 ( -19.14% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/09/17 23:12
終値2026/09/17 00:00
収益2026/06/30
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
  • SECフォーム10-K
  • SECフォーム10-Q
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
  • アナリストリサーチレポート
  • Blue Matrix
市場価格30年
  • 株価
  • 配当、分割、措置
  • ICEマーケットデータ
  • SECフォームS-1
所有権10年
  • トップ株主
  • インサイダー取引
  • SECフォーム4
  • SECフォーム13D
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
  • SECフォーム10-K
  • SECフォームDEF 14A
主な進展10年
  • 会社からのお知らせ
  • SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

LANXESS Aktiengesellschaft 13 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。33

アナリスト機関
Anil ShenoyBarclays
James KnightBarclays
Andres Castanos-MollorBerenberg

どこでもより良い投資判断を

スキャンしてダウンロード
App Store を開くGoogle Play を開く
Chrome ウェブストア
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
データソースを見る
市場
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
投資のアイデア
  • 割安企業
  • 配当優良企業
  • インサイダー買い
  • 原子力
  • 自律走行車
  • 人工知能
  • 暗号資産とブロックチェーン
  • サイバーセキュリティ
  • さらにアイデア
株価コミュニティ
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
機能とツール
  • ポートフォリオ・トラッカー
  • ストックスクリーナー&アラート
  • 語りと公正な値
  • 配当金計算機
ニュース & 発見
  • 最新の在庫ニュース
  • グローバルマーケットインサイト
  • The Foxhole ブログ
  • 投資のアイデア
  • コミュニティの物語
  • 新着情報
Simply Wall St
  • プランと料金
  • 広告
  • 会社概要
  • お問い合わせ
  • 採用情報
  • ヘルプセンター
  • 株式投資を学ぶ
  • アフィリエイト・プログラム
  • ビジネス
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • ご利用条件
  • プライバシーポリシー
  • AI利用規約
  • 金融サービスガイド